Stroke:超高龄患者的运动和认知能力影响对血压与卒中之间的相关性

2013-05-06 geniusgodyu 互联网

流行病学研究中得出的超高龄患者中高血压与卒中的关系结果不一。荷兰Leiden大学医学中心老年医学与老年学系的Behnam Sabayan博士等人通过研究发现:对于超高龄患者,运动和认知能力对血压与卒中之间的相关性存在影响。相关论文发表在Stroke杂志2012年11月6日在线版上。 研究人员从人群为基础的Leiden85岁以上人群研究中纳入513为85岁的患者。基线测定收缩压、舒张压、平均动脉压

流行病学研究中得出的超高龄患者中高血压与卒中的关系结果不一。荷兰Leiden大学医学中心老年医学与老年学系的Behnam Sabayan博士等人通过研究发现:对于超高龄患者,运动和认知能力对血压与卒中之间的相关性存在影响。相关论文发表在Stroke杂志2012年11月6日在线版上。

研究人员从人群为基础的Leiden85岁以上人群研究中纳入513为85岁的患者。基线测定收缩压、舒张压、平均动脉压和脉压差。分别评估日常生活活动力和Mini精神状态测试以估计体能和认知功能的水平。使用Cox回归分析估计5年卒中风险。

结果发现:在整个队列中,除了脉压差和卒中存在可能相关(风险比[HR],0.80 [95% 可信区间 [CI], 0.66–0.98])外,其他血压变量与卒中风险都没有相关。在那些运动功能下降的患者中,收缩压较高(HR, 0.74 [95% CI, 0.59–0.92])、平均动脉压较高(HR: 0.68 [95% CI, 0.47–0.97])和脉压差较高(HR, 0.71 [95% CI, 0.55–0.93])与卒中风险降低相关。同样,在认知功能障碍的患者中,收缩压较高与卒中风险较低相关(HR, 0.80 [95% CI, 0.65–0.98])。在没有认知功能障碍的患者舒张压较高(HR: 1.98 [95% CI, 1.21–3.22])和平均动脉压较高(HR, 1.70 [95% CI, 1.08–2.68])与卒中风险较高相关。

研究人员得出结论:对于超高龄患者,运动和认知功能障碍对血压和卒中之间的相关性存在影响

doi: 10.1161/​STROKEAHA.112.663062
PMC:
PMID:

High Blood Pressure, Physical and Cognitive Function, and Risk of Stroke in the Oldest Old

Behnam Sabayan, MD, MSc, Peter van Vliet, MD, PhD, Wouter de Ruijter, MD, PhD, Jacobijn Gussekloo, MD, PhD, Anton J.M. de Craen, PhD and Rudi G.J. Westendorp, MD, PhD

Background—Epidemiological studies have shown mixed findings on the association between hypertension and stroke in the oldest old. Heterogeneity of the populations under study may underlie variation in outcomes. We examined whether the level of physical and cognitive function moderates the association between blood pressure and stroke. Methods—We included 513 subjects aged 85 years old from the population-based Leiden 85-plus Study. Systolic blood pressure, diastolic blood pressure, mean arterial pressure, and pulse pressure were measured at baseline. Activities of daily living and Mini-Mental State Examination were assessed to estimate level of physical and cognitive function, respectively. Five-year risk of stroke was estimated with Cox regression analysis. Results—In the entire cohort, there were no associations between various measures of blood pressure and risk of stroke except for the inverse relation between pulse pressure and stroke risk (hazard ratio [HR], 0.80 [95% confidence interval [CI], 0.66–0.98]). Among subjects with impaired physical functioning, higher systolic blood pressure (HR, 0.74 [95% CI, 0.59–0.92]), mean arterial pressure (HR: 0.68 [95% CI, 0.47–0.97]), and pulse pressure (HR, 0.71 [95% CI, 0.55–0.93]) were associated with reduced risk of stroke. Likewise, among subjects with impaired cognitive functioning, higher systolic blood pressure was associated with reduced risk of stroke (HR, 0.80 [95% CI, 0.65–0.98]). In subjects with unimpaired cognitive functioning, higher diastolic blood pressure (HR: 1.98 [95% CI, 1.21–3.22]) and mean arterial pressure (HR, 1.70 [95% CI, 1.08–2.68]) were associated with higher risk of stroke. Conclusions—Our findings suggest that impaired physical and cognitive function moderates the association between blood pressure and stroke.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2045946, encodeId=b59f20459460f, content=<a href='/topic/show?id=1f1410283499' target=_blank style='color:#2F92EE;'>#高龄患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102834, encryptionId=1f1410283499, topicName=高龄患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Jul 02 04:57:00 CST 2013, time=2013-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837111, encodeId=6d29183e111bc, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sat Oct 05 17:57:00 CST 2013, time=2013-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1416018, encodeId=3ba114160189b, content=<a href='/topic/show?id=99fb1028231b' target=_blank style='color:#2F92EE;'>#高龄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102823, encryptionId=99fb1028231b, topicName=高龄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307c3130149, createdName=xlysu, createdTime=Wed May 08 14:57:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2045946, encodeId=b59f20459460f, content=<a href='/topic/show?id=1f1410283499' target=_blank style='color:#2F92EE;'>#高龄患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102834, encryptionId=1f1410283499, topicName=高龄患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Jul 02 04:57:00 CST 2013, time=2013-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837111, encodeId=6d29183e111bc, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sat Oct 05 17:57:00 CST 2013, time=2013-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1416018, encodeId=3ba114160189b, content=<a href='/topic/show?id=99fb1028231b' target=_blank style='color:#2F92EE;'>#高龄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102823, encryptionId=99fb1028231b, topicName=高龄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307c3130149, createdName=xlysu, createdTime=Wed May 08 14:57:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2045946, encodeId=b59f20459460f, content=<a href='/topic/show?id=1f1410283499' target=_blank style='color:#2F92EE;'>#高龄患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102834, encryptionId=1f1410283499, topicName=高龄患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Jul 02 04:57:00 CST 2013, time=2013-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837111, encodeId=6d29183e111bc, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Sat Oct 05 17:57:00 CST 2013, time=2013-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1416018, encodeId=3ba114160189b, content=<a href='/topic/show?id=99fb1028231b' target=_blank style='color:#2F92EE;'>#高龄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102823, encryptionId=99fb1028231b, topicName=高龄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307c3130149, createdName=xlysu, createdTime=Wed May 08 14:57:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
    2013-05-08 xlysu

相关资讯

Nature:阿尔茨海默氏症新病因解读

  由美国麻省大学医学院、波恩大学和德国先进欧洲学习与研究中心的研究人员组成的一个国际研究小组,在新研究中证实一个众所周知的免疫炎症过程在阿尔茨海默氏症的病理学中发挥了重要的作用。这一过程导致生成了成熟的促炎性细胞因子白细胞介素1β(IL-1B),与机体抵御感染相关,因此被确立为类风湿性关节炎的一个临床靶点。这一发表在《自然》(Nature)杂志上的研究发现指出了破坏IL-1B生成的药物,例如类风

BIB:阿尔茨海默病评估量表可能不完善(ADNI研究)

  研究者从ADNI(阿尔辞海默病神经影像创新)研究中选取了193例受试者的资料,以评价ADAS-Cog(阿尔茨海默病评估量表-认知行为部分)评分是否仍有需要改进之处。受试者的平均年龄为74岁,47%为女性,平均Mini精神状态检查评分为23分。资料包括基线、6个月、12个月和24个月时675项指标的评分。   结果未发现可能限制量表识别低功能或高功能患者状态变化的总体效能的地板效应和天花板效应

Age Ageing:老年人有“心”病易伤“脑”

  英国一项基于人群的队列研究显示,老年人心血管风险的增加可能与其认知功能的加速衰退相关。论文11月25日在线发表于《年龄与衰老》(Age Ageing)杂志。   研究纳入英国老龄化纵向研究中的老年人。临床转归指标包括总体认知、记忆和执行功能。结果显示,在随访4年时,与弗雷明汉卒中危险评分(FSR)较低的四分位者相比,FSR最高四分位者的总体认知、记忆和执行功能得分较低。研究对象的收

CA Cancer J Clin:乳腺癌化疗后多出现轻度认知障碍

  近日一项大规模荟萃分析得出结论——乳腺癌患者在化疗治疗后面临轻度认知功能障碍的风险。这项研究结果发表在最新一期的《临床肿瘤学杂志》(Journal of Clinical Oncology)。“一般而言,化疗后认知功能障碍仅为轻度且局限于言语能力方面,如措词能力,和空间视觉能力,如在陌生环境中很容易迷路,” Heather Jim博士说,他是本文首席作者,也是位于弗罗里达州的H. Lee Mo

Neurology:血液透析可导致认知障碍

  关于血透患者认知功能的详细报道很少。为此,美国波士顿塔斯夫医学中心神经科的Mark J. Sarnak博士等人进行了一项研究,研究结果在线发表在2013年1月9日的Neurology杂志上。研究结果发现:血透患者中认知功能差的发生率很高,主要影响的是执行功能。执行功能差的危险因素包含了血管危险因素和血管病。MMSE正常不能排除认知功能受损。   该研究为横断面队列研究。研究人员对314位血透

Diabetes Care:临床和亚临床大血管疾病标志物可预测老年T2DM患者认知减退

大血管疾病促使2型糖尿病患者认知加速减退的风险增加。为了确定在认知健康的老年2型糖尿病患者中大血管疾病指标与认知改变的相关性,来自英国苏格兰爱丁堡大学人口健康科学中心的Price博士等人进行了一项研究,研究发现,老年2型糖尿病患者中风、亚临床心区不适标志物和全身性动脉粥样硬化与认知减退具有显著相关性。研究结果在线发表于2013年4月11日的美国《糖尿病护理》(Diabetes Care)杂志上。研